>>live from Denver, Colorado. It's the Q covering com vault. Go 2019. Brought to you by combo. >>Welcome to the Cube. Lisa Martin with student A man we're covering Day one of convo go 19 from Colorado. Stew and I are pleased to welcome to the Cube one of combo longtime customers from AstraZeneca. We have Scott 100 global infrastructure surfaces. Director. Hey, Scott. >>Good afternoon. >>Good afternoon. Welcome to the Cube. AstraZeneca is a name that probably a lot of folks know in the bio medical pharmaceutical space. But for those that don't give us an overview of AstraZeneca. What you guys are what you d'oh! >>Obviously we're we're, ah, bio pharmaceutical company with global presence way be used. The primary care takes off. Medicines be sale throughout the world. So everything from Kearney care to tiu oncology onda also are massive. That diabetes franchise, as well as other core core therapies that are used by our patients, were like, >>All right, So, Scott, maybe bring us inside. What is data mean to your organization? >>And it means loss. Lots of things taxes and cut through our organization from go boat framed in that next molecules to discover them bleeding edge medicines for our patients all the way to have our sales People commercial use data to identify the patients for further rate kid as well and ofcourse, backoffice tree I t enabling functions like each HR and finances. Well, therefore, is this apartment for business >>you've got Global infrastructure service could just lay out a little bit what that entails and how data fits into the picture, what's in your purview and what you have to work with other groups on. >>So my idea looks after architecture, designing governance and for cyber security infrastructure, savage seas, AstraZeneca. So So we be like after within either on premise within their own try our own data centers are in the public load as well. So as you can imagine, their movement on Deron realms and that can environment is pivotal to the coming been successful go forward >>when every time we, you know, you talk about data being the life blood of an organization or the new oil when we're talking about a patient information and the information that could be used to find the next, you know, cure for a particular disease, this it's this is literally life and death data on the ability to have access to it, but also to make sure that it's protected and secure table stakes. Right, so talk to us about when you came on board, he said. Around six years ago, before we went live knowing how critical data is toe AstraZeneca's business, What was the data strategy like a few years ago? >>It was pretty convoluted six years ago when am I fought during the actual Danica over largely exhaust to various companies? So their strategy basically that have one. We don't really have much of a strategy for looking after our deal with five or six different backup products, but then the cinnamon on lane their storage products is now. So over the last 56 years, can stealing that down to one key data storage provider in the APP and also for backup from the store combo. We do still have some leg. It's a very fast environments, but they're being decommissioned. That moved over combo. I speak >>from a what can I t. An initial initiative perspective. A few years ago, six years ago, we didn't have a date, a strategy. What was some of the you know from the top, down from the C suite down, maybe from the board down saying, Hey, guys, we have to get our hands around. I mean, this is before GDP are But in terms of the opportunities that I provided the company, where did that initiative come from? And a new year old come about now. But you guys want a couple of different routes, Talk to us a little bit about that initiative and the initial directions to where you are now. >>Yes, O. R. Xia Old Smalley obviously had a vision for how the country is going to progress. Set sail in his tenure on a massive pile that was understanding with our data waas how it was used on but most importantly have it was protected as well. And so that kind of drove the insertion from likes of HCL Congress and emphasis into looking after our own environment. You can, after our own idea for choosing strategies as well, so that organically company could grow based on best directions for using that there that we could meet from what we had the radio through collaboration with other bio farmers is a game just for the greater good of fame than that. That next medical molecules to help proficient. All right, >>Scott, have you been toe the combo Cho shows before? >>Second thing second time. Tell us a >>little >>bit about you know what brings you to the show? A lot of announcements here. Anything jump out so far? >>Yeah, it is interesting to see some of the new collaborations are Sorry. Party sees it comes I'll be making over the last little well Hedvig acquisition looks looks breaks on the metallic venture that, doomed for public sass is, well, looks like equals x, a n and ammunition and came environments that convo play on. So I think things to very good moves. >>So you're leveraging Public Cloud. How does Khan Vault fit into that? You're to be used babies >>convoked for for M backing up on restoring and our public load environments. Whether we need a B s robotics, start watching in the jury's there with You're in the club zero stack as well. And then we're in the process of bringing on lane production environments and Google Cloud Platform zone. So having that one back up in the store strategies pivotal Isabella's enabling us to move our day off using visibility solution to get calm. Boulders now, which is very powerful, is >>one of the things I noticed when I watched the video that combo has done with you. And they actually shared a quote from you during the keynote before Actually, before everyone walked. It is, you said this constant evolution that come about is delivering was one of the things that that you really like. From a business perspective, Combo has done a lot of evolving in the last nine months with the new leadership. It's too. And you were talking about some of the new technology, some of the new announcements from that evolutionary perspective and what you guys like about it. What are you seeing in terms of them going forward? Are you saying hey, there really listening? They're looking at use cases like ours, learning from it to not only make the technology is better, but to expand their portfolio. >>I mean, for a lot of it's based in the constant evolution of the FBI's that convo used for access and videos need parts. Technology will be backing up of the M two, backing up kubernetes containers and using that in the Secret Service's environment is Val to Tolliver's to ensure that whatever it comes to get from Lourdes cannot feel like several. It's computing environments that don't understand what what they put watch. So we can either reuse it, destroy, are used different manner, so that for us, that's great. Because obviously for our own C A c d pay planes, they're all FBI driven on to be able to use a convert production. The same kind of fashion is >>so, Scott, do you keep up on the quarterly cadence that combo doing and is there anything, uh, kind of either on the road map for things that you're asking for that would make your environment even better? >>And we're kind of used the 90 day cadences for ourselves to ensure that our own strategies are kept in check and we could take advantage off in your aunties are coming not only from convo but for other parts of our the infrastructure really be now for our only storage or a video. Various other providers that be used for insurance are dead as a decibel and used in a proper fashion. I >>want to get into a little bit of the use case, I knew that you had a number of different competing backup solutions in place. Did you start from a data started perspective, like within one division or one part of the company to maybe pilot, because you ended up with a whole bunch of different software solutions in there. Now you standardize on combo, walk us through that process, those decisions and what you're getting by having this now single pane of less >>some of the populated back up in the store sprawl was caused by individual parts of his had been able to do a little thing having little ineighty budget. So give it up. Some parts of business want to use a backup from Veritas or the emcee products that were in play at the time when we source between IBM and HDL chores each pdp for a pre media centers. So I decided another another backup restore productive in the mix. So for us, it just became untenable when we started insourcing, you know, to build a support team support organization to work after that many technologies was pretty difficult hands by way to go for 11 stop strategy. >>You said in the video. That combo had a pretty significantly higher success rate compared to some of the other solutions, so that must have made it a no brainer. >>So our backup critical applications is 99.8% successful to stay on, and that's that. That's what come won't get themselves. So that was a great comfort on the series. Is more and more of our applications move over on the convo platform, then have ah more wrong deeds approached, You know, backup success, but success in the store and say the things as well as Bella's, you know, using the analytics on a more timely fashion again for for drug and manufacturing research. >>So I know that you guys looked at our sorry spoke with a number of combat customers before you made this decision. And now here you are, on the other side of the coin, talking to a lot of combo customers. What advice would you give companies in any industry who in almost 2020 may not have a really robust data strategy? Your recommendations >>should look it over, not just our backup in the store solution. You know, the could base, which has put together for involves very powerful from the beta index. Ease with information going through construe the product to you can use out for things like D. R H A and also immigration off records. Two different defense centers are different parts of public low dreamer, you know, And the new new vision that I have for the analytics is very powerful as well. Forget the name of this tour today that someone that, you know, maybe we've started to use ourselves in a big way. We've got a little science team within my operation, which is made in that they are not coming, that they're more efficient manner. Feed that into our. Praised the architecture so that they could take advantage of what? Worried they got their own confines and makes out with what they need to do for for new discoveries. >>Scott, thank you for joining. Stewing me on the cube today, sharing with us what you're doing at AstraZeneca and looking forward to hearing the next molecule that discovers some great breakthrough. >>Thank you. >>First to Minutemen. I'm Lisa Martin. You're watching the cue from combo go 19